The impact of an electronic monitoring and reminder device on patient compliance with antihypertensive therapy:  a randomized controlled trial

Research output: Contribution to journalJournal articlepeer-review

Standard

The impact of an electronic monitoring and reminder device on patient compliance with antihypertensive therapy :  a randomized controlled trial. / Christensen, Arne; Christrup, Lona Louring; Fabricius, Paul Erik; Chrostowska, Marzena; Wronka, Michal; Narkiewicz, Krzysztof; Hansen, Ebba Holme.

In: Journal of Hypertension, Vol. 28, No. 1, 2010, p. 194-200.

Research output: Contribution to journalJournal articlepeer-review

Harvard

Christensen, A, Christrup, LL, Fabricius, PE, Chrostowska, M, Wronka, M, Narkiewicz, K & Hansen, EH 2010, 'The impact of an electronic monitoring and reminder device on patient compliance with antihypertensive therapy:  a randomized controlled trial', Journal of Hypertension, vol. 28, no. 1, pp. 194-200. https://doi.org/10.1097/HJH.0b013e328331b718

APA

Christensen, A., Christrup, L. L., Fabricius, P. E., Chrostowska, M., Wronka, M., Narkiewicz, K., & Hansen, E. H. (2010). The impact of an electronic monitoring and reminder device on patient compliance with antihypertensive therapy:  a randomized controlled trial. Journal of Hypertension, 28(1), 194-200. https://doi.org/10.1097/HJH.0b013e328331b718

Vancouver

Christensen A, Christrup LL, Fabricius PE, Chrostowska M, Wronka M, Narkiewicz K et al. The impact of an electronic monitoring and reminder device on patient compliance with antihypertensive therapy:  a randomized controlled trial. Journal of Hypertension. 2010;28(1):194-200. https://doi.org/10.1097/HJH.0b013e328331b718

Author

Christensen, Arne ; Christrup, Lona Louring ; Fabricius, Paul Erik ; Chrostowska, Marzena ; Wronka, Michal ; Narkiewicz, Krzysztof ; Hansen, Ebba Holme. / The impact of an electronic monitoring and reminder device on patient compliance with antihypertensive therapy :  a randomized controlled trial. In: Journal of Hypertension. 2010 ; Vol. 28, No. 1. pp. 194-200.

Bibtex

@article{b51ed4e0011211df825d000ea68e967b,
title = "The impact of an electronic monitoring and reminder device on patient compliance with antihypertensive therapy:  a randomized controlled trial",
abstract = "BACKGROUND: High blood pressure (BP) significantly increases overall cardiovascular risk, the incidence of ischemic heart disease and stroke. One of the most important causes of insufficient BP control is low treatment compliance. Reminders and electronic compliance monitoring have been shown to be effective in improving patient compliance to some extent, but the combined effect has not been documented. OBJECTIVE: To assess the impact of an electronic reminder and monitoring device on patient compliance and BP control. METHODS: All patients received medical treatment with telmisartan once daily and were randomized to either electronic compliance monitoring with a reminder and monitoring device or standard therapy for 6 months. Both groups were crossed over after 6 months. Intervention effectiveness was assessed using self-reported compliance and BP. RESULTS: Data from 398 patients were analysed. In the first half of the study, patients using the device reported 91% compliance versus 85% in the control group. This difference diminished after crossover (88 versus 86%). BP was not affected. Electronic monitoring data on compliance revealed taking, dosing and timing compliance between 45 and 52% in study group 1, and between 32 and 38% in study group 2. CONCLUSION: The Helping Hand reminder device was most suitable if used for newly diagnosed hypertensive patients, when it improved compliance by 6%. With the present medical treatment, the device does not have any influence on BP control, but with less forgiving medications, the device might make a significant difference. The use of the device can be an easy and effective way to improve compliance in selected patients.",
keywords = "Former Faculty of Pharmaceutical Sciences",
author = "Arne Christensen and Christrup, {Lona Louring} and Fabricius, {Paul Erik} and Marzena Chrostowska and Michal Wronka and Krzysztof Narkiewicz and Hansen, {Ebba Holme}",
year = "2010",
doi = "10.1097/HJH.0b013e328331b718",
language = "English",
volume = "28",
pages = "194--200",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams & Wilkins, Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - The impact of an electronic monitoring and reminder device on patient compliance with antihypertensive therapy

T2 -  a randomized controlled trial

AU - Christensen, Arne

AU - Christrup, Lona Louring

AU - Fabricius, Paul Erik

AU - Chrostowska, Marzena

AU - Wronka, Michal

AU - Narkiewicz, Krzysztof

AU - Hansen, Ebba Holme

PY - 2010

Y1 - 2010

N2 - BACKGROUND: High blood pressure (BP) significantly increases overall cardiovascular risk, the incidence of ischemic heart disease and stroke. One of the most important causes of insufficient BP control is low treatment compliance. Reminders and electronic compliance monitoring have been shown to be effective in improving patient compliance to some extent, but the combined effect has not been documented. OBJECTIVE: To assess the impact of an electronic reminder and monitoring device on patient compliance and BP control. METHODS: All patients received medical treatment with telmisartan once daily and were randomized to either electronic compliance monitoring with a reminder and monitoring device or standard therapy for 6 months. Both groups were crossed over after 6 months. Intervention effectiveness was assessed using self-reported compliance and BP. RESULTS: Data from 398 patients were analysed. In the first half of the study, patients using the device reported 91% compliance versus 85% in the control group. This difference diminished after crossover (88 versus 86%). BP was not affected. Electronic monitoring data on compliance revealed taking, dosing and timing compliance between 45 and 52% in study group 1, and between 32 and 38% in study group 2. CONCLUSION: The Helping Hand reminder device was most suitable if used for newly diagnosed hypertensive patients, when it improved compliance by 6%. With the present medical treatment, the device does not have any influence on BP control, but with less forgiving medications, the device might make a significant difference. The use of the device can be an easy and effective way to improve compliance in selected patients.

AB - BACKGROUND: High blood pressure (BP) significantly increases overall cardiovascular risk, the incidence of ischemic heart disease and stroke. One of the most important causes of insufficient BP control is low treatment compliance. Reminders and electronic compliance monitoring have been shown to be effective in improving patient compliance to some extent, but the combined effect has not been documented. OBJECTIVE: To assess the impact of an electronic reminder and monitoring device on patient compliance and BP control. METHODS: All patients received medical treatment with telmisartan once daily and were randomized to either electronic compliance monitoring with a reminder and monitoring device or standard therapy for 6 months. Both groups were crossed over after 6 months. Intervention effectiveness was assessed using self-reported compliance and BP. RESULTS: Data from 398 patients were analysed. In the first half of the study, patients using the device reported 91% compliance versus 85% in the control group. This difference diminished after crossover (88 versus 86%). BP was not affected. Electronic monitoring data on compliance revealed taking, dosing and timing compliance between 45 and 52% in study group 1, and between 32 and 38% in study group 2. CONCLUSION: The Helping Hand reminder device was most suitable if used for newly diagnosed hypertensive patients, when it improved compliance by 6%. With the present medical treatment, the device does not have any influence on BP control, but with less forgiving medications, the device might make a significant difference. The use of the device can be an easy and effective way to improve compliance in selected patients.

KW - Former Faculty of Pharmaceutical Sciences

U2 - 10.1097/HJH.0b013e328331b718

DO - 10.1097/HJH.0b013e328331b718

M3 - Journal article

C2 - 19770778

VL - 28

SP - 194

EP - 200

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - 1

ER -

ID: 16976660